A new study reports on the importance of REM sleep for the developing brain and questions the increasing use of REM disrupting medications in children.
Treatment resistant bipolar disorder patients experienced a reversal of a key symptom 40 minutes after a single infusion of ketamine, a new study reports.
Researchers report a single dose of a widely prescribed antidepressant causes quantifiable changes in the brain within a matter of hours.
A new study reports autism risks appear to be attributed to maternal depression during pregnancy, and not antidepressant medications as previously believed.
A common antidepressant proves effective in easing agitation associated with Alzheimer's disease, a new study reports.
Researchers identify a molecular pathway which accelerates the time taken for antidepressants to work in mouse models.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
A synthetic compound, decynium-22, is able to turn off SERT in the brain, enhancing the effectiveness of SSRIs.
A new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.
Researchers identify a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. The experimental results explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature.